X
Edition:
United States

  • Business
    • Business Home
    • Legal
    • Deals
    • Aerospace & Defense
    • Finance
    • Autos
    • Reuters Summits
    • ADventures
    • Data Dive
  • Markets
    • Markets Home
    • U.S. Markets
    • European Markets
    • Asian Markets
    • Global Market Data
    • Indices
    • Stocks
    • Bonds
    • Currencies
    • Commodities
    • Futures
    • Funds
    • Earnings
    • Dividends
  • World
    • World Home
    • U.S.
    • Special Reports
    • Reuters Investigates
    • Euro Zone
    • Middle East
    • China
    • Japan
    • Mexico
    • Brazil
    • Africa
    • Russia
    • India
  • Politics
    • Politics Home
    • Polling Explorer
    • Live: Trump's First 100 Days
    • What Voters Want
    • Supreme Court
  • Tech
    • Technology Home
    • Science
    • Top 100 Global Innovators
    • Media
    • Environment
    • Innovation
  • Commentary
    • Commentary Home
    • Podcasts
  • Breakingviews
    • Breakingviews Home
    • Breakingviews Video
  • Money
    • Money Home
    • Retirement
    • Lipper Awards
    • Analyst Research
    • Stock Screener
    • Fund Screener
  • Life
    • Health
    • Sports
    • Arts
    • Entertainment
    • Oddly Enough
  • Pictures
    • Pictures Home
    • The Wider Image
    • Photographers
    • Focus 360
  • Video
Gluten not linked to babies' risk of diabetes: study
  • Africa
    América Latina
  • عربي
    Argentina
  • Brasil
    Canada
  • 中国
    Deutschland
  • España
    France
  • India
    Italia
  • 日本
    México
  • РОССИЯ
    United Kingdom
  • United States
Health News | Fri May 20, 2011 | 3:54pm EDT

Gluten not linked to babies' risk of diabetes: study

By Adam Marcus | NEW YORK

NEW YORK (Reuters Health) - For babies at higher risk of childhood diabetes because of family history or genes, a gluten-free diet in the first year of life does not lower the chances of developing the disease, German researchers report.

The findings undercut previous studies, including work from the same scientists, suggesting that babies exposed to gluten as part of their early diet might be more likely to develop type 1 diabetes later in childhood.

Although the new study included only 150 children, Dorothy Becker, director of the diabetes program at Children's Hospital of Pittsburgh, told Reuters Health the results are reasonably clear.

"It doesn't mean that it if you did a huge study there wouldn't be an effect (of gluten)," said Becker, who was not involved in the study. "But it makes it unlikely."

Gluten is the protein in wheat and other grains that makes dough elastic and gives bread its chewiness. Roughly 1 percent of people in the United States have a condition called celiac disease, in which immune reactions to gluten damage the intestines.

Each year about 20 kids per 100,000 under the age of 10 in the U.S. are diagnosed with type 1 diabetes, according to the National Institutes of Health. In contrast with type 2 diabetes, which is usually a disease of adults and associated with old age or obesity, type 1 diabetes typically strikes children.

Many of them likely inherited a genetic predisposition to the disease from their parents. Yet genes alone don't fully explain why people develop the condition. Other factors, such as environmental exposures, are thought to be necessary to trigger it.

In the latest study, the researchers followed 150 babies with at least one parent or sibling who had been diagnosed with type 1 diabetes -- marked by the death of islet cells in the pancreas that secrete the hormone insulin. The body requires insulin to convert dietary sugars into energy.

Half of the children were exposed to gluten in their diet for the first time at the age of six months. For the rest, exposure to the protein was delayed until after their first birthday.

The different diets appeared to have no impact on the babies' ability to grow or gain weight.

By age 3, three children exposed to gluten early had developed type 1 diabetes, compared to four in the late-exposure group. Signs that the children had developed immune reactions to their own islet cells - a possible precursor to diabetes, especially in those with a genetic predisposition for the disorder - appeared in 11 children given gluten at six months of age, compared to 13 who first ate gluten when they were 12 months old.

Some research has suggested that delaying exposure to gluten can increase the risk of developing celiac disease. However, the German scientists said they found no evidence for such a link.

Roughly 30 percent of parents said they did not strictly follow the diet plan. Still, the researchers said, the results of the study show that although delaying the introduction of gluten into a baby's diet causes no harm, it doesn't appear to reduce the risk of diabetes or immune-related early-indicators of insulin problems.

The researchers did not respond to requests for comment on their study, which appeared online last month in the journal Diabetes Care.

Research into other potential food triggers for type 1 diabetes is ongoing. Last November, researchers in Finland reported that babies with a genetic predisposition for type 1 diabetes who were fed an infant formula called Nutramigen were about half as likely as those given conventional cows' milk formulas to show signs of islet cell autoimmunity later in childhood. The milk proteins in Nutramigen (sold as Enfamil by Mead Johnson & Co.) are altered in a way that makes them more tolerable to the immune system.

Becker is helping to lead a large international trial funded by the National Institutes of Health to further explore the Finish findings. The results of that study, which includes nearly 2,200 babies, are expected in 2017, she said.

SOURCE: bit.ly/hzGutn Diabetes Care, online April 22, 2011.

Next In Health News

Health insurer Anthem says Cigna cannot terminate merger agreement

WASHINGTON Health insurer Anthem Inc said on Tuesday that Cigna Corp could not unilaterally terminate an agreement between the two companies to merge.

Merck stopping late stage study as another Alzheimer's drug fails

Merck & Co Inc said on Tuesday it will halt a late-stage trial of an Alzheimer's drug after it was determined that it had no chance of working, marking the latest in a long line of crushing disappointments in efforts to find an effective treatment for the mind-wasting disease.

Brain damage in former players fuels soccer 'heading' fears

LONDON Scientists have found signs of brain damage that could cause dementia in a handful of former soccer players, fuelling worries about the danger of frequent knocks from heading the ball or colliding with others on the field.

MORE FROM REUTERS

Sponsored Content

From Around the WebPromoted by Revcontent

Trending Stories

    Pictures

    Photos of the day

    Sponsored Topics

    X
    Follow Reuters:
    • Follow Us On Twitter
    • Follow Us On Facebook
    • Follow Us On RSS
    • Follow Us On Instagram
    • Follow Us On YouTube
    • Follow Us On LinkedIn
    Subscribe: Feeds | Newsletters | Podcasts | Apps
    Reuters News Agency | Brand Attribution Guidelines | Careers

    Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Learn more about Thomson Reuters products:

    Eikon
    Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface
    Elektron
    Everything you need to empower your workflow and enhance your enterprise data management
    World-Check
    Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks
    Westlaw
    Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology
    ONESOURCE
    The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs
    CHECKPOINT
    The industry leader for online information for tax, accounting and finance professionals

    All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

    • Site Feedback
    • Corrections
    • Advertising Guidelines
    • Cookies
    • Terms of Use
    • Privacy Policy